INSIGHTS ON DRUG DEVELOPMENT

• A Global CRO/CDMO Where Science Is A Way Of Thinking

  Our service offerings in discovery, development and manufacturing cover multiple domains across small molecules, large molecules, antibody-drug conjugates (ADC) and oligonucleotides.

• Identifying New, Enhanced Device Delivery Solutions For Chronic Diseases

  Needle innovations, including the usage of shorter needles with ultra-thin wall technology for prefilled syringes, support the delivery of drugs with greater volumes and viscosities, which greatly enhances end-user experience.

• Taste Masking 101: Optimize Taste And Improve Patient Outcomes

  Learn how swallowability and palatability play key factors related to patient acceptability and product development and about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies.

• How To Achieve Precise And Flexible Dosing With Multiparticulates

  For orally delivered medicines, developers often must balance a drug’s “curb appeal” — its specific delivery mechanism, taste, ease of administration, and convenience — with safety and efficacy.

• Improving Compliance And Accuracy Of Dosing In Pediatrics And Patients With Dysphagia

  6/22/2021

  1 in 17 people will develop dysphagia, or difficulty or discomfort in swallowing, in their lifetime. Even for those with a healthy swallowing function, it can be a challenge to swallow solid oral medications.

• Stable Microcaps® Formulation Masks Bitter HIV Drug For Young Children

  6/22/2021

  The challenge was developing a taste masked, convenient dosage formulation of a very bitter API for patients two-years old and older undergoing treatment of HIV infection.

• Dry Syrup Formulation Masks Bitter Taste In Easy-To-Swallow Suspension

  6/22/2021

  A global pharmaceutical needed formulation and development work regarding a dry syrup alternative for Fexofenadine suitable for children who have difficulty swallowing the available pill dosage.

• Analytical Services: Risk Management In PFS Components Selection For Sensitive Biological Drug Formulations

  6/10/2021

  Choosing the right containers and materials is critical but also difficult, and no methodology is available to quickly assess the risk of drug/device interaction. Here are two risk-based test methodologies to select the optimum closure materials and the correct syringe silicone level at the early phase of drug development to improve the time to market predictability.